EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Impact of COVID-19 disease on the male factor in reproductive medicine – how-to advise couples undergoing IVF/ICSI

Julia Stark, Stefan P Kuster, Vera Hungerbühler

Reproduction, Fertility and Development · 2024

DOI: 10.1071/rd23205 ↗

At a glance

Übersichtsarbeit in Reproduction, Fertility and Development, 2024. Written by Julia Stark and 2 co-authors. Institution: Kantonsspital St. Gallen, Department of Gynecological Endocrinology and Reproductive Medicine, St. Gallen, Switzerland. Major MEDLINE topics: COVID-19, Reproductive Medicine. Cited 3 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Context

The COVID-19 pandemic has caused widespread concern about its potential impact on various aspects of human health.

Aims

This narrative review aims to summarise the current knowledge about the impact of COVID-19 on sperm quality and its effect on assisted reproductive technology.

Methods

In this narrative review, a literature search using the PubMed and MEDLINE databases was conducted to identify relevant original research articles published up to 29 January 2023.

Results

Thirty original studies were included in our review. There is evidence that SARS-CoV-2 is detectable in seminal fluid during the acute phase of infection and for up to 1 month. However, the fact that SARS-CoV-2 is barely detectable in semen makes sexual transmission very unlikely. COVID-19 infection has been associated with the following changes in sperm quality: morphology, altered motility, changed DNA fragmentation-index (DFI), decreased sperm concentration, lower total number of sperm, and a significant increase in leukocytes and cytokines. The effects mostly seem to be reversible and have not been shown to negatively affect the outcome of assisted reproductive technology but should lead to further research concerning the health of the offspring, because a correlation of increased DFI after COVID-19 even 5 months after disease could be assumed.

Conclusions

The findings of this narrative review suggest that SARS-CoV-2 may harm sperm quality in the acute phase.

Implications

A recovery time of at least 3 months regarding assisted reproductive therapy could be reasonable.

Subjects

MeSH terms (MEDLINE)

COVID-19Reproductive MedicineMaleHumansSemenSperm Injections, IntracytoplasmicPandemicsDNA FragmentationSARS-CoV-2SpermatozoaReproductive Techniques, Assisted

Authors and institutions

  • Kantonsspital St. Gallen, Department of Gynecological Endocrinology and Reproductive Medicine, St. Gallen, Switzerland.
  • Kantonsspital St. Gallen, Division of Infectious Diseases and Hospital Epidemiology, Rorschacher Str. 95, 9007 St. Gallen, Switzerland.
  • Kantonsspital St. Gallen, Department of Gynecological Endocrinology and Reproductive Medicine, Fiore Praxis AG, Brauerstrasse 95, 9016 St. Gallen, Switzerland.

Cite

APA

Stark, J., Kuster, S. P., & Hungerbühler, V. (2024). Impact of COVID-19 disease on the male factor in reproductive medicine – how-to advise couples undergoing IVF/ICSI. Reproduction, Fertility and Development. https://doi.org/10.1071/rd23205

Vancouver

Stark J, Kuster SP, Hungerbühler V. Impact of COVID-19 disease on the male factor in reproductive medicine – how-to advise couples undergoing IVF/ICSI. Reproduction, Fertility and Development. 2024. doi:10.1071/rd23205

BibTeX
@article{Stark2024,
  author = {Stark, Julia and Kuster, Stefan P and Hungerbühler, Vera},
  title = {Impact of COVID-19 disease on the male factor in reproductive medicine – how-to advise couples undergoing IVF/ICSI},
  journal = {Reproduction, Fertility and Development},
  year = {2024},
  doi = {10.1071/rd23205}
}
Start for free →